Flip the DNA Nanoswitch, Power the Clinical App
A Molecular Interaction Detection Platform Uses a Gel-based Readout
Cell Therapy Production Moves to Factory Floor
Assembly Lines Are Preparing to Churn out Safe, Reliable, and Affordable Constructs
Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Immuno-Oncology Enhances Battlespace Awareness
Molecular Imaging Could Help Clinicians Accurately Select Patients for Treatment or Monitoring
For full access to this article login to GEN Select now.
U.K. Works to Keep Its Edge
- 2011 was a tough year for the U.K.’s biotech industry, especially with several big pharma closures. The good news is that there is new growth in development and manufacturing of biotherapeutics. Pfizer and Novartis may have shut down their U.K. sites, but as the saying goes, when one ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.